Cargando…

Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden: Two case reports

RATIONALE: In the setting of metastatic or locally advanced adrenocortical carcinoma, a limited number of therapies are available and their efficacy is generally below modest. The backbone of treatment remains surgery, even for metastatic disease, whenever it is possible, and mitotane. Chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mota, Jose Mauricio, Sousa, Luana Guimarães, Braghiroli, Maria Ignez, Siqueira, Luiz Tenório, Neto, João Evangelista Bezerra, Chapchap, Paulo, Hoff, Ana A. de Oliveira, Hoff, Paulo M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314733/ https://www.ncbi.nlm.nih.gov/pubmed/30593126 http://dx.doi.org/10.1097/MD.0000000000013517

Ejemplares similares

Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinoma
por: Marta, Guilherme Nader, et al.
Publicado: (2021)

Complete Radiological Response of Recurrent Metastatic Adrenocortical Carcinoma to Pembrolizumab and Mitotane
por: Alam, Walid, et al.
Publicado: (2021)

SAT-178 Incidence, Patterns of Clinical Presentation, and Outcomes of Patients with Brain Metastasis Due to Adrenocortical Carcinoma
por: Amorim, Larissa Costa, et al.
Publicado: (2020)

MicroRNA Era: The Importance for Diagnosis and Prognosis of Adrenocortical Tumors
por: Bezerra, João Evangelista, et al.
Publicado: (2014)

Next-generation Sequencing-based genomic profiling: Fostering innovation in cancer care?
por: Fernandes, Gustavo S., et al.
Publicado: (2017)

Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2018)

Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
por: de M Rêgo, Juliana Florinda, et al.
Publicado: (2017)

SAT-165 Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma
por: Lacombe, Amanda Meneses Ferreira, et al.
Publicado: (2020)

Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas
por: Braghiroli, Maria Ignez, et al.
Publicado: (2015)

Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma
por: Lacombe, Amanda Meneses Ferreira, et al.
Publicado: (2020)

METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours
por: Glasberg, João, et al.
Publicado: (2022)

METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours
por: Glasberg, João, et al.
Publicado: (2022)

Acute Acalculous Cholecystitis in a Patient with Metastatic Renal Cell Carcinoma Treated with Sunitinib
por: da Fonseca, Leonardo Gomes, et al.
Publicado: (2014)

Pembrolizumab-Induced Lichen Planus Pemphigoides in a Patient with Metastatic Adrenocortical Cancer: A Case Report and Literature Review
por: Madan, Vrinda, et al.
Publicado: (2023)

Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma
por: Senda, Masaya, et al.
Publicado: (2023)

Combination of Irinotecan and a Platinum Agent for Poorly Differentiated Neuroendocrine Carcinomas
por: Ramella Munhoz, Rodrigo, et al.
Publicado: (2013)

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
por: Habra, Mouhammed Amir, et al.
Publicado: (2019)

SUN-351 Are We Underestimating The Role Of Systemic Chemotherapy In The Treatment Of Localized And Advanced Adrenocortical Carcinoma?
por: Ferreira, Amanda, et al.
Publicado: (2019)

Adjuvant radiotherapy for the primary treatment of adrenocortical carcinoma: are we offering the best?
por: Srougi, Victor, et al.
Publicado: (2017)

Symptomatic Hypoglycemia Related to Inappropriately High IGF-II Serum Levels in a Patient with Desmoplastic Small Round Cell Tumor
por: Barra, Williams Fernandes, et al.
Publicado: (2010)

Rivaroxaban: An Affordable and Effective Alternative in Cancer-Related Thrombosis?
por: Xavier, Flávia Dias, et al.
Publicado: (2016)

A case of metastatic adrenocortical carcinoma
por: Kuthiah, N, et al.
Publicado: (2019)

Successful Treatment of Metastatic Gallbladder Carcinoma with a High Tumor Mutational Burden Using Pembrolizumab
por: Uehara, Sanae, et al.
Publicado: (2023)

Clinical and Pathological Features of Metastatic Adrenocortical Carcinoma
por: Guiomar, Joana Reis, et al.
Publicado: (2021)

Metastatic Hepatocellular Carcinoma Responsive to Pembrolizumab
por: Truong, Phu, et al.
Publicado: (2016)

Metastatic Porocarcinoma Effectively Managed by Pembrolizumab
por: Singh, Arminder, et al.
Publicado: (2021)

Combination of Capecitabine and Oxaliplatin is an Effective Treatment Option for Advanced Neuroendocrine Tumors
por: Ferrarotto, Renata, et al.
Publicado: (2013)

Complications from carcinoid syndrome: review of the current evidence
por: Mota, José Mauricio, et al.
Publicado: (2016)

Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab
por: Casey, R.T., et al.
Publicado: (2018)

Recurrent Hypokalemia as an Unusual Presentation for Metastatic Adrenocortical Cancer
por: Mirza, Naomi, et al.
Publicado: (2022)

Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
por: Barnhart, Carrie
Publicado: (2015)

Pembrolizumab and tavokinogene telseplasmid electroporation in metastatic melanoma
por: Dollin, Yonatan, et al.
Publicado: (2020)

Efficacy of pembrolizumab rechallenge for metastatic urothelial carcinoma
por: Nishimura, Nobutaka, et al.
Publicado: (2022)

A case of secondary adrenocortical insufficiency due to isolated adrenocorticotropic hormone deficiency with empty sella syndrome after pembrolizumab treatment in a patient with metastatic renal pelvic cancer
por: Nagai, Takashi, et al.
Publicado: (2021)

Histological scores and tumor size on stage II in adrenocortical carcinomas
por: Oliveira, Rui Caetano, et al.
Publicado: (2021)

Safety and Effectiveness of Chemotherapy for Metastatic Esophageal Cancer in a Community Hospital in Brazil
por: Victor, Carolina Ribeiro, et al.
Publicado: (2019)

Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer
por: Salman, Pamela, et al.
Publicado: (2018)

Efficacy of oral metformin in a patient with metastatic adrenocortical carcinoma: Examination of mechanisms and therapeutic implications
por: Peixoto, RD, et al.
Publicado: (2018)

Establishment of a mouse xenograft model of metastatic adrenocortical carcinoma
por: Morin, Aurélie, et al.
Publicado: (2017)

Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
por: Fojo, Tito, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qgrnjg8mub8l9h4g0u130e7286